AEMD
Income statement / Annual
Last year (2024), Aethlon Medical, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Aethlon Medical, Inc.'s net income was -$12.21 M.
See Aethlon Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$0.00
|
$574,245.00
|
$294,165.00
|
$659,104.00
|
$650,187.00
|
$229,625.00
|
$149,625.00
|
$392,073.00
|
$886,572.00
|
$762,417.00
|
| Cost of Revenue |
$359,057.00 |
$265,300.00 |
$154,217.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$359,057.00 |
$308,945.00 |
$139,948.00 |
$659,104.00 |
$650,187.00 |
$229,625.00 |
$149,625.00 |
$392,073.00 |
$886,572.00 |
$762,417.00 |
| Gross Profit Ratio |
0 |
0.54 |
0.48 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$2.52 M
|
$2.75 M
|
$2.34 M
|
$2.07 M
|
$927,000.00
|
$896,000.00
|
$586,000.00
|
$673,000.00
|
$782,000.00
|
$1.03 M
|
| General & Administrative
Expenses |
$7.43 B
|
$7.51 M
|
$5.69 M
|
$4.90 M
|
$4.10 M
|
$2.98 M
|
$2.21 M
|
$2.86 M
|
$3.04 M
|
$2.31 M
|
| Selling & Marketing
Expenses |
-$7.42 B
|
$4.96 M
|
$5.03 M
|
$3.65 M
|
$2.48 M
|
$3.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.76 M
|
$12.47 M
|
$10.72 M
|
$8.55 M
|
$6.58 M
|
$6.23 M
|
$4.98 M
|
$6.49 M
|
$5.27 M
|
$4.76 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$12.28 M |
$12.62 M |
$10.72 M |
$8.55 M |
$6.98 M |
$6.23 M |
$5.49 M |
$7.39 M |
$5.27 M |
$7.30 M |
| Cost And Expenses |
$12.64 M |
$12.62 M |
$10.72 M |
$8.55 M |
$6.98 M |
$6.23 M |
$5.49 M |
$7.39 M |
$5.27 M |
$7.30 M |
| Interest Income |
$0.00 |
$10,973.00 |
$0.00 |
$0.00 |
$54,232.00 |
$220,487.00 |
$361,597.00 |
$304,330.00 |
$573,782.00 |
$440,276.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$1,580.00 |
$54,232.00 |
$220,487.00 |
$361,597.00 |
$276,689.00 |
$429,099.00 |
$322,129.00 |
| Depreciation &
Amortization |
$359,057.00
|
$240,892.00
|
$123,685.00
|
$39,939.00
|
$26,366.00
|
$30,695.00
|
$35,658.00
|
$32,413.00
|
$38,524.00
|
$37,352.00
|
| EBITDA |
-$11.85 M
|
-$11.66 M
|
-$10.30 M
|
-$7.85 M
|
-$6.30 M
|
-$5.97 M
|
-$5.30 M
|
-$6.97 M
|
-$4.35 M
|
-$6.50 M
|
| EBITDA Ratio |
0 |
-20.3 |
-35 |
-11.91 |
-9.08 |
-25.99 |
-32.05 |
-15.47 |
-4.9 |
-5.19 |
| Operating Income Ratio
|
0
|
-20.72
|
-35.43
|
-11.97
|
-9.12
|
-26.13
|
-32.29
|
-15.55
|
-4.95
|
-5.24
|
| Total Other
Income/Expenses Net |
$428,394.00
|
-$131,148.00
|
$0.00
|
$0.00
|
-$450,053.00
|
-$220,487.00
|
-$868,721.00
|
-$1.21 M
|
-$573,782.00
|
-$2.99 M
|
| Income Before Tax |
-$12.21 M |
-$12.03 M |
-$10.42 M |
-$7.89 M |
-$6.38 M |
-$6.22 M |
-$5.70 M |
-$7.31 M |
-$4.96 M |
-$6.98 M |
| Income Before Tax Ratio
|
0
|
-20.95
|
-35.43
|
-11.97
|
-9.81
|
-27.09
|
-38.09
|
-18.64
|
-5.59
|
-9.15
|
| Income Tax Expense |
$3.00 |
$0.00 |
-$4,799.00 |
-$6,369.00 |
-$6,093.00 |
-$24,785.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$12.21 M |
-$12.03 M |
-$10.42 M |
-$7.89 M |
-$6.37 M |
-$6.19 M |
-$5.68 M |
-$7.28 M |
-$4.87 M |
-$6.80 M |
| Net Income Ratio |
0 |
-20.95 |
-35.41 |
-11.97 |
-9.8 |
-26.98 |
-37.96 |
-18.56 |
-5.5 |
-8.92 |
| EPS |
-4.86 |
-5.86 |
-7.06 |
-6.52 |
-18.67 |
-51.27 |
-69.17 |
-140.57 |
-98.85 |
-182.25 |
| EPS Diluted |
-4.86 |
-5.86 |
-7.06 |
-6.52 |
-18.67 |
-51.27 |
-69.17 |
-140.57 |
-98.85 |
-182.25 |
| Weighted Average Shares
Out |
$2.51 M
|
$2.05 M
|
$1.48 M
|
$1.21 M
|
$341,484.00
|
$120,831.00
|
$82,114.00
|
$51,762.00
|
$49,291.00
|
$37,296.00
|
| Weighted Average Shares
Out Diluted |
$2.51 M
|
$2.05 M
|
$1.48 M
|
$1.21 M
|
$341,484.00
|
$120,831.00
|
$82,114.00
|
$51,762.00
|
$49,291.00
|
$37,296.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
